Category: Fresenius Medical Care
Here's a look at some of the top legal news stories for medical device companies this week: J&J's Conor MedSystems can't slip $100M Biotronik lawsuit; Supreme Court declines review of Baxter/Fresenius patent row; Medtronic, Edwards ink $750M heart valve settlement; Pa. Supreme Court to review $28M Zimmer verdict; Laid off Italian workers sue Haemonetics.
Fresenius escapes for good a $24 million patent infringement loss to dialysis rival Baxter International after the U.S. Supreme court declines to review the case.
Dialysis services provider Fresenius gives its renal research arm a new look, renaming it "Frenova" and reasserting its focus on new product development.
Dialysis giant Fresenius (NYSE:FMS) re-introduced its renal research branch, renaming it "Frenova" and reiterating the group's commitment to developing novel therapies.
Here's a look at some of the top Wall Street stories for medical device companies this week.
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
, Goldman Sachs
, Kohlberg Kravis Roberts & Co. L.P.
, Semler Scientific
, Terumo Corp.
, The Blackstone Group LP
, TPG Capital
, Analogic Corp.
, Fresenius Medical Care
, GE Healthcare
, Getinge AB
QMed releases a list of the 5 worst-performing medical device companies of early 2014, including Siemens, GE and Fresenius, among others.
MASSDEVICE ON CALL — Medtech giants have seen Wall Street bumps so far this year, but several of the company's in the industry's top 40 haven't been so fortunate.
Fresenius renews its pact for the purchase of NxStage Medical's System One hemodialysis device.
Fresenius (NYSE:FMS) and NxStage Medical (NSDQ:NXTM) said they extended a supply deal for NxStage's System One hemodialysis device until 2016.
A Federal Circuit court refuses to re-hear the case after a lower court throws out Baxter's $23.5 million win against Fresenius, which was charged with infringement of hemodialysis patents.